Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 25, 2001

View Archived Issues

ArQule and Camitro agree to merge

Cambridge Drug Discovery and Teijin alliance makes progress

Tamoxifen for breast cancer prevention does not alter cardiovascular risk

Potential of telomerase inhibitors for chemoprevention emerges from recent research

Antibacterial eyedrops to be jointly developed by SSP and InSite

New ROCK inhibitor with potential for the treatment of glaucoma licensed out by Welfide

Research at Johns Hopkins provides proof of concept for gene therapy of cardiac arrhythmias

Virco and Tibotec announce merger

NDA filed in U.S. for once-daily Xatral

FDA issues approval letter for Axcan's Canasa for ulcerative proctitis

Caspase inhibitors show potential for reducing myocyte death

Andrx begins basic research program for the use of statins in Alzheimer's disease

Donitriptan expected to represent significant step forward in acute migraine therapy

Results with extended-release ciprofloxacin product promising, reports DepoMed

First IVR-based product for HRT advances toward market launch

Emisphere seeks FDA clearance to begin trials of new drug delivery agent for heparins

Molecular Templates: new company focused on anticancer agents

TKR-2993: new antifungal antibiotic identified by Takara Shuzo

Cardiovascular and metabolic effects of LY-117018 explored in rat model

Potent inhibitors of phosphodiesterase type 4 described by Euroceltique

New agents described by Kyorin for lowering lipid levels

Introgen awarded SBIR grant to study INGN-241 as lung cancer treatment

Syk inhibitors and their use claimed by Yamanouchi

New leucomycin derivatives under study as antibacterials at Meiji Seika

Patent issued to Welfide covering new series of potential antidepressants

Mutual salts, prodrugs of amlodipine and atorvastatin and their use

Collateral Therapeutics gains option to UCSF cell cycle regulation technology

Human growth-promoting compound optioned by Atrix from Tulane University

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...